Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
067080:KOSDAQ
Dae Hwa Pharm Co Ltd
â‚©14,000.00
+6.06%
(+800.00) 1D
May 22, 3:30:24 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 067080...
Open
â‚©13,250
High
â‚©14,230
Low
â‚©13,250
Mkt. cap
260.63B
Avg. vol.
96.80K
Volume
103.51K
Dividend
1.07%
Quarterly dividend
â‚©37
Ex-dividend date
Jun 29, 2026
P/E ratio
134.83
52-wk high
â‚©24,900
52-wk low
â‚©12,590
EPS
â‚©104
Shares outstanding
18.62M
No. of employees
365
News stories
From sources across the web
About Dae Hwa Pharm Co Ltd
CEOEun-Seok Kim | Byung-Tae Noh
Employees365
Founded1984
Headquarters-
SectorPharmaceutical industry
Websitedhpharm.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
36.67B
35.96B
36.73B
33.70B
Cost of goods sold
24.90B
24.39B
24.78B
22.06B
Cost of revenue
24.90B
24.39B
24.78B
22.06B
Research and development expenses
1.20B
1.54B
1.08B
1.37B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.23B
9.51B
9.27B
9.19B
Operating expense
10.63B
11.29B
10.91B
10.94B
Total operating expenses
35.54B
35.68B
35.68B
33.00B
Operating income
1.13B
285.17M
1.05B
699.48M
Other non operating income
156.30M
408.88M
292.85M
765.41M
EBT including unusual items
-144.08M
-362.44M
286.29M
5.00B
EBT excluding unusual items
-8.96M
-394.43M
139.10M
314.23M
Income tax expense
153.08M
154.81M
465.08M
1.68B
Effective tax rate
-106.25%
-42.71%
162.45%
33.52%
Other operating expenses
34.80M
24.91M
205.24M
89.90M
Net income
-414.11M
-682.25M
-428.57M
3.18B
Net profit margin
-1.13%
-1.90%
-1.17%
9.43%
Earnings per share
-
-
-
-
Interest and investment income
26.46M
59.26M
-14.79M
55.04M
Interest expense
-1.26B
-1.17B
-1.09B
-1.27B
Net interest expenses
-1.23B
-1.12B
-1.11B
-1.21B
Depreciation and amortization charges
96.46M
90.96M
85.92M
89.49M
EBITDA
2.70B
1.85B
2.62B
2.26B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer